Navigation Links
Recognized Dermatology Expert Dr. Zoe Draelos Joins Histogen Scientific Advisory Board
Date:11/13/2008

Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Zoe Diane Draelos, M.D., clinical and research dermatologist and President of Dermatology Consulting Services, has joined the Company's Scientific Advisory Board.

San Diego (PRWEB) November 13, 2008 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced that Zoe Diane Draelos, M.D., clinical and research dermatologist and President of Dermatology Consulting Services, has joined the Company's Scientific Advisory Board.

Dr. Draelos is a board certified dermatologist in private practice, and a recognized expert in cosmetic and biologically active skin medication research. As President and Primary Investigator for Dermatology Consulting Services, a company she founded in 1988, Dr. Draelos is focused on providing education, developing formulation technology, and conducting clinical studies in association with the pharmaceutical and cosmetics industry.

Histogen recently announced the creation of Histogen Aesthetics LLC, a venture developing products for the growing medical aesthetic industries based on the Company's core technology. Dr. Draelos' addition to the Scientific Advisory Board will be invaluable as Histogen Aesthetics moves forward with product launches and further clinical evaluations in this area.

"To have Dr. Draelos, a renowned dermatologist, and skin biologist with focused expertise in cosmetic dermatology, join Histogen's SAB validates our technology and potential for treatments in the growing specialty of aesthetic medicine," stated Lawrence A. Rheins, Ph.D., President of Histogen Aesthetics LLC. "We are excited to have the opportunity to utilize her insight and clinical expertise as we prepare for product launches in post-resurfacing a
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
2. Two Metabolex Projects Recognized in Windhovers Top 10 Lists for Partnering Opportunities
3. BioTrends Research Group, Inc. Recognized as One of Philadelphias Fastest Growing Privately Held Companies
4. Global Vision Recognized for Helping Pharmaceutical Companies Achieve Complete Artwork and Copy Accuracy in their Packaging Process
5. Lilly Recognized as One of the Worlds Top Biopharmaceutical Employers
6. Monsanto Recognized as Top Biotechnology Employer by Science Magazine
7. Titan Spine Teams Up With Syndicom, Inc. to Utilize Internationally Recognized SpineConnect Collaboration Platform
8. Quintiles Recognized Among Best Companies to Work For in Brazil
9. MedNet Solutions Again Recognized as one of the Fastest Growing US Companies
10. Ohio Recognized as National Leader for Business Development and Job Creation
11. Kiwa Bio-Tech Receives Nationally Recognized Organic Products Certification
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...VYVANSE is the first stimulant to establish durati... administration in adults with ADHD , , HOLLYWO...lc (LSE: SHP, Nasdaq: SHPGY ), the global specia...ults from a Phase 3b study that found VYVANSE(R) (...ificant efficacy at 14 hours after administration ...
(Date:7/1/2009)...TUSTIN, Calif., July 1 P...oday announced that it has been awarded a European... biological agents to labels for diagnostic and th...known as In-Line labeling, was developed for the p...but is applicable to other agents as well. A stud...
(Date:6/30/2009)... international team of researchers has modified ch...tremely efficient light antennae of bacteria. The ...hese light antennae. This is the first step to con...eaf. The researchers will be publishing an article...ition of the PNAS journal in the week starting 2...
(Date:6/30/2009)...BETHLEHEM, Pa. and NEWTON, Mass., June 30 /PRNewsw...f Microfluidics International Corporation (OTC Bul...I) have formed a strategic alliance to help biopha...nd reliable nanotechnology and formulation methods...ctive Pharmaceutical Ingredients (APIs). , , Pa...
Breaking Biology Technology:Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 2Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 3Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 4Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 5Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 6Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 7Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment 8Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 4First step to converting solar energy using 'artificial leaf' 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 2Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization 3
... Trace amounts of ribonuclease (...tage experiments. Since RNases are , ... your skin, in the , air, on an..., open to the air--it is importa... or eliminate RNase contamination. However, dete...
...cient Cellular Fractionation for RNA , ... Ambion,s Protein and RNA Isolation Sys...simple procedure to isolate both , ...erimental , sample. Cultured ce... frozen, or treated with RNA stabilizatio...
..., Because of its apparent speci...ease of use, RNAi technology is greatly , ...ation of , disease-relevant gen... and basic research efforts. To ensure...owever, proper experimental design and controls ar...
... mir Vana miRNA Detection Kit ,...r siRNA in as little as 10 ng total RNA , ...ed to optimize hybridization , or washing... tube procedure eliminates the need to transfer ,... Multiple target detection -- Detect small RNAs a...
Other Biology Technology:Combat RNase Contamination in the Lab 2Combat RNase Contamination in the Lab 3Combat RNase Contamination in the Lab 4Combat RNase Contamination in the Lab 5Efficient Cellular Fractionation for RNA , and Protein Isolation 2Efficient Cellular Fractionation for RNA , and Protein Isolation 3Efficient Cellular Fractionation for RNA , and Protein Isolation 4Efficient Cellular Fractionation for RNA , and Protein Isolation 5Efficient Cellular Fractionation for RNA , and Protein Isolation 6Efficient Cellular Fractionation for RNA , and Protein Isolation 7Designing Controls for siRNA , Experiments 2Designing Controls for siRNA , Experiments 3Designing Controls for siRNA , Experiments 4Designing Controls for siRNA , Experiments 5Detecting Attomole Amounts of Small RNA 2Detecting Attomole Amounts of Small RNA 3
(Date:7/2/2009)... the National Oceanography Centre, Southampton, ha...c knowledge to investigate the distribution of a n...ts, published this week in the Journal of Biogeog...nd the speciation and radiation of a major seafloo... years of Earth,s history. , In deep seas all o...
(Date:7/2/2009)...uly 2nd 2009. A new measurement system for the det...rd of the research vessel Polarstern. Whales are u...end the greater part of their life under water. On...an be seen when they surface, and this can even ha...Visual sightings by marine mammal observers are th...
(Date:7/2/2009)...., an assistant professor of pathology and laborat...ence Center at Houston, has received a Career Deve...ion. , The award will support Smith,s research ...Hemophilia A, a bleeding disorder, whose immune sy...ects about one in every 5,000 males born in the Un...
(Date:7/2/2009)...As flowering plants like giant trees quickly rose ...s period, the ferns that had preceded them hardly ...rished. While modern tropical rain forests were be...rienced a flowering of their own species diversity...ication," said Duke University researcher Eric Sch...
Breaking Biology News(10 mins):Evolution: Crabs go deep to avoid hot water 2All in sight 2UT scientist receives hemophilia research award 2Ferns took to the trees and thrived 2UD researchers show that plants can accumulate nanoparticles in tissues 5832 1UD researchers show that plants can accumulate nanoparticles in tissues 5832 2UD researchers show that plants can accumulate nanoparticles in tissues 5832 3 New technique enables assessment of drought performance 5827 1Lakeside Systems Inc Unifies Integrated Healthcare Delivery System under New Brand 3A Lakeside Community Healthcare 29630 1Lakeside Systems Inc Unifies Integrated Healthcare Delivery System under New Brand 3A Lakeside Community Healthcare 29630 2Lakeside Systems Inc Unifies Integrated Healthcare Delivery System under New Brand 3A Lakeside Community Healthcare 29630 3Lakeside Systems Inc Unifies Integrated Healthcare Delivery System under New Brand 3A Lakeside Community Healthcare 29630 4Morgenthaler Closes Ninth Fund at 24400 Million 29625 1Morgenthaler Closes Ninth Fund at 24400 Million 29625 2Morgenthaler Closes Ninth Fund at 24400 Million 29625 3Morgenthaler Closes Ninth Fund at 24400 Million 29625 4
... -- Carnegie Mellon University scientists have mad...ng of why HIV enters immune cells with ease. The r...cell, it dramatically lowers the energy required f...he virus to infect immune cells. The finding, in p...ta to conduct future computer simulations of HIV d...
...wth, darker leaves, a different way of branching -...are often substantially different from the laborat... of many plant biologists. Which detailed differen...lar circle or the subtropics, from America, Africa...by research teams from Tübingen, Germany, and Cal...
... at Johns Hopkins have discovered one way the p53 ...ancer cells. Their report will be published in the...eam identified a tiny bit of genetic code, a micro...nny ability to kill cells likely to become maligna...RNAs are small chains of ribonucleic acid (RNA) ma...
...dn’t pan out. Neither did two other potential anti...gent desert shrub is now a front- runner in ongoin...als, known to inhibit inflammation, cancer and oth...ving longer. , Today at the annual meeting of the ... scientist Richard A. Miller reports early results...
Other Biology News:Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily 2Carnegie Mellon scientists find key HIV protein makes cell membranes bend more easily 3One species, many genomes 2One species, many genomes 3Common cancer gene sends death order to tiny killer 2Agent slows aging in mice 2
Polyethylene Glycol 8000, 1 kg. PEG 8000.Used in differential DNA precipitation. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Panomer 9 oligodeoxynucleotides are random primers that are labeled at the 5' end with our proprietary Alexa Fluor dyes and they are useful for assessing microarray spot morphology, hybridization pot
Mycoplasma tested
The Spheroplast Kit contains qualified reagents for the preparation of yeast spheroplasts. The reagents have been optimized for use with Pichia pastoris and are guaranteed to generate 70% spheroplast
Biology Products: